We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Beleaguered Wockhardt’s Regulatory Hurdles Increase With Second FDA Import Ban
Beleaguered Wockhardt’s Regulatory Hurdles Increase With Second FDA Import Ban
The FDA Tuesday hit Wockhardt with a second “import alert,” banning drug products from its Chikalthana plant in western India — the latest in a spate of regulatory actions taken against the struggling drugmaker.